Aedan J. Rourke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aedan J. Rourke has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Addriana R. Odisho
McMaster University
3 shared publicationsGeoff B. Coombs
McMaster University
3 shared publications- Jack Bone
Department of Kinesiology McMaster University Hamilton Ontario Canada
3 shared publications Jenna A. Nash
McMaster University
3 shared publications- Jeremy J. Walsh
McMaster University
3 shared publications - Baraa K. Al-Khazraji
McMaster University
2 shared publications
Latest Publications
- 19 November 2026
- Published by American Physiological Society in Journal of Applied Physiology
Isocapnic breathing mitigates cerebral blood flow reductions after ketone monoester supplementation
Ketone monoester (KME) ingestion lowers cerebral blood flow (CBF), likely due to reduced arterial carbon dioxide (P a CO 2 ). We tested the hypothesis that maintaining end-tidal CO 2 (P ET CO 2 ; surrogate for P a CO 2 ) following KME ingestion would prevent reductions in CBF and improve cerebrovascular reactivity (CVR) to CO 2 compared to free-breathing. In a single-blinded randomized crossover design, twenty-three adults (age=22±2 yrs) ingested 0.6 g·kg -1 KME and breathed either room air (poikilocapnia) or a gas mixture that clamped P ET CO 2 at baseline (isocapnia) for 60 min. CVR to CO 2 was assessed at targeted P ET CO 2 of +3, +6, and +9 mmHg above baseline. CBF was assessed using duplex ultrasound of extracranial arteries and transcranial Doppler ultrasound of the middle cerebral artery. Venous β-hydroxybutyrate, pH, and bicarbonate were measured. Outcomes were assessed at baseline, 45-, and 60-min post-supplementation. P ET CO 2 was higher during isocapnia at 45 min (3.9±3.8 mmHg; P2 was reduced following KME ingestion regardless of condition ( P2 following KME ingestion are due to reduced P a CO 2 in response to metabolic acidosis. Strategies that buffer metabolic acidosis likely will mitigate CBF reductions following acute KME ingestion.
- 19 November 2026
- Published by American Physiological Society in Journal of Applied Physiology
Isocapnic breathing mitigates cerebral blood flow reductions after ketone monoester supplementation
Ketone monoester (KME) ingestion lowers cerebral blood flow (CBF), likely due to reduced arterial carbon dioxide (P a CO 2 ). We tested the hypothesis that maintaining end-tidal CO 2 (P ET CO 2 ; surrogate for P a CO 2 ) following KME ingestion would prevent reductions in CBF and improve cerebrovascular reactivity (CVR) to CO 2 compared to free-breathing. In a single-blinded randomized crossover design, twenty-three adults (age=22±2 yrs) ingested 0.6 g·kg -1 KME and breathed either room air (poikilocapnia) or a gas mixture that clamped P ET CO 2 at baseline (isocapnia) for 60 min. CVR to CO 2 was assessed at targeted P ET CO 2 of +3, +6, and +9 mmHg above baseline. CBF was assessed using duplex ultrasound of extracranial arteries and transcranial Doppler ultrasound of the middle cerebral artery. Venous β-hydroxybutyrate, pH, and bicarbonate were measured. Outcomes were assessed at baseline, 45-, and 60-min post-supplementation. P ET CO 2 was higher during isocapnia at 45 min (3.9±3.8 mmHg; P2 was reduced following KME ingestion regardless of condition ( P2 following KME ingestion are due to reduced P a CO 2 in response to metabolic acidosis. Strategies that buffer metabolic acidosis likely will mitigate CBF reductions following acute KME ingestion.
- 10 August 2025
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2581-2582
Reply to: 'Cerebral blood flow with exogenous ketosis: The full picture?’
- 10 August 2025
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2581-2582
Reply to: 'Cerebral blood flow with exogenous ketosis: The full picture?’
- Open Access
- 11 May 2025
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2525-2541
Acute ketone monoester ingestion lowers resting cerebral blood flow: a randomized cross‐over trial
Exogenous ketone monoester (KME) supplements rapidly increase plasma beta‐hydroxybutyrate (β‐OHB) and may impact cerebral blood flow (CBF). However, it is currently unknown how acute KME ingestion impacts resting CBF and whether differences in KME dose have differential effects on CBF regulation. The purpose of this study was to investigate the effect of two separate KME doses on resting CBF in young adults. On separate days and in a double‐blind, placebo‐controlled, cross‐over design, 20 participants (10 females; aged 23 ± 3 years) ingested either: (1) High‐KME (0.6 g kg −1 β‐OHB); (2) Low‐KME (0.3 g kg −1 β‐OHB); or (3) placebo drink, and quietly rested for 120 min. Global CBF (gCBF) was assessed using duplex ultrasound of the internal carotid and vertebral arteries, and transcranial Doppler ultrasound was used to assess middle cerebral artery blood velocity at baseline, 45 min and 120 min post‐ingestion. End‐tidal CO 2 () was measured using a gas analyser. β‐OHB was measured in venous blood. At 45 min post‐ingestion, gCBF was significantly reduced by 10.6% in Low‐KME and by 14.6% in High‐KME compared to baseline. At 120 min, gCBF returned towards baseline in Low‐KME, whereas gCBF was further reduced by 19.1% in High‐KME compared to baseline. KME dose‐dependent reductions in may have contributed to these reductions in gCBF following KME ingestion. These novel findings provide a foundational characterization of the impact of KME on resting CBF, which prompts further investigation building on these results to isolate underlying mechanisms and develop dosing protocols to mitigate potential CO 2 disruptions. image Key points: Beta‐hydroxybutyrate (β‐OHB) is a signalling molecule and β‐OHB infusion increases cerebral blood flow (CBF) in humans. Ingestion of higher doses of a ketone monoester (KME) supplement have been shown to lower blood pH and arterial CO 2 , which are important regulators of CBF. This double‐blind and placebo‐controlled cross‐over study tested the effects of two separate KME doses (Low‐KME and High‐KME) on resting CBF, end‐tidal CO 2 and systemic haemodynamics over a 2 h period post‐ingestion in young adults. Low‐KME reduced CBF 45 min post‐ingestion and High‐KME reduced CBF at both 45 and 120 min post‐ingestion, which corresponded with dose‐dependent reductions in end‐tidal CO 2 . The findings from this trial represent a foundational characterization of the effects of KME dose on resting CBF.
- 11 May 2025
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2525-2541
Open AccessAcute ketone monoester ingestion lowers resting cerebral blood flow: a randomized cross‐over trial
Exogenous ketone monoester (KME) supplements rapidly increase plasma beta‐hydroxybutyrate (β‐OHB) and may impact cerebral blood flow (CBF). However, it is currently unknown how acute KME ingestion impacts resting CBF and whether differences in KME dose have differential effects on CBF regulation. The purpose of this study was to investigate the effect of two separate KME doses on resting CBF in young adults. On separate days and in a double‐blind, placebo‐controlled, cross‐over design, 20 participants (10 females; aged 23 ± 3 years) ingested either: (1) High‐KME (0.6 g kg −1 β‐OHB); (2) Low‐KME (0.3 g kg −1 β‐OHB); or (3) placebo drink, and quietly rested for 120 min. Global CBF (gCBF) was assessed using duplex ultrasound of the internal carotid and vertebral arteries, and transcranial Doppler ultrasound was used to assess middle cerebral artery blood velocity at baseline, 45 min and 120 min post‐ingestion. End‐tidal CO 2 () was measured using a gas analyser. β‐OHB was measured in venous blood. At 45 min post‐ingestion, gCBF was significantly reduced by 10.6% in Low‐KME and by 14.6% in High‐KME compared to baseline. At 120 min, gCBF returned towards baseline in Low‐KME, whereas gCBF was further reduced by 19.1% in High‐KME compared to baseline. KME dose‐dependent reductions in may have contributed to these reductions in gCBF following KME ingestion. These novel findings provide a foundational characterization of the impact of KME on resting CBF, which prompts further investigation building on these results to isolate underlying mechanisms and develop dosing protocols to mitigate potential CO 2 disruptions. image Key points: Beta‐hydroxybutyrate (β‐OHB) is a signalling molecule and β‐OHB infusion increases cerebral blood flow (CBF) in humans. Ingestion of higher doses of a ketone monoester (KME) supplement have been shown to lower blood pH and arterial CO 2 , which are important regulators of CBF. This double‐blind and placebo‐controlled cross‐over study tested the effects of two separate KME doses (Low‐KME and High‐KME) on resting CBF, end‐tidal CO 2 and systemic haemodynamics over a 2 h period post‐ingestion in young adults. Low‐KME reduced CBF 45 min post‐ingestion and High‐KME reduced CBF at both 45 and 120 min post‐ingestion, which corresponded with dose‐dependent reductions in end‐tidal CO 2 . The findings from this trial represent a foundational characterization of the effects of KME dose on resting CBF.
- 23 November 2024
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2583-2585
Food for thought: implications of exercise‐induced changes to cerebral glucose metabolism in ageing and Alzheimer's disease
- 23 November 2024
- Published by Wiley in The Journal of Physiology
- Vol. 604 (6) , 2583-2585
Food for thought: implications of exercise‐induced changes to cerebral glucose metabolism in ageing and Alzheimer's disease